Crown Bio

CrownBio is a leading translational technology company making precision medicine a reality. By helping biopharmaceutical companies address some of the most pressing challenges in today’s drug discovery for oncology, cardiovascular, and metabolic diseases, CrownBio brings clarity to drug development worldwide. CrownBio's premier cancer and metabolic disease translational platforms help clients accelerate their new drug development programs. CrownBio develops world-leading preclinical efficacy models and provides in vitro and in vivo testing services as well as preclinical research products. CrownBio is a global company with facilities in the United States, the United Kingdom, China, and Taiwan, China.